FGF-Silyl-Heparin Cerebral Aneurysm Coils

Information

  • Research Project
  • 6482691
  • ApplicationId
    6482691
  • Core Project Number
    R43NS043809
  • Full Project Number
    1R43NS043809-01
  • Serial Number
    43809
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/2002 - 22 years ago
  • Project End Date
    6/30/2004 - 20 years ago
  • Program Officer Name
    GOLDMAN, STEPHEN
  • Budget Start Date
    7/1/2002 - 22 years ago
  • Budget End Date
    6/30/2004 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/20/2002 - 22 years ago

FGF-Silyl-Heparin Cerebral Aneurysm Coils

DESCRIPTION (provided by applicant): Cerebral aneurysms can be life threatening and because the blood vessel is weak they are subject to rupture. Platinum coils are currently used as an experimental treatment for inoperable cerebral aneurysms and function by inducing thrombosis within the aneurysm. The metal/thrombus fills the aneurysm, thereby restoring a more normal blood flow in the blood vessel. Currently used coils do not stimulate tissue in-growth into the aneurysm or blood vessel wall, thereby leaving the vessel wall weakened and with a continued susceptibility to rupture. We propose improving aneurysm coils by coating a modified, proprietary heparin onto the surface, and then using the affinity of hepann to further complex basic fibroblast growth factor (FGF-2). The coating is simple and cost-effective as it is performed using adsorption and affinity techniques. The FGF will encourage local cell migration and proliferation resulting in a strengthening of the aneurysm wall and a filling of the aneurysm with cellular material. Our initial studies suggest that the heparin can be modified to alter the rate of release from a substrate, a factor that could help control the bioavailability in vivo. The Phase I studies will develop the coated coils and perform initial animal evaluations.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R43
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    105000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:105000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOSURFACE ENGINEERING TECHNOLOGIES
  • Organization Department
  • Organization DUNS
  • Organization City
    Rockville
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20850
  • Organization District
    UNITED STATES